On the other hand, analysis of the p-AURKA/AURKA ratio between early and advanced tumor stages of CRC and lung cancer groups resulted in a 1.88-fold increment (P < 0.001), and 1.14-fold elevation (P = 0.021) of p-AURKA/AURKA ratio, respectively. This evidence concerns the gene AURKA and lung carcinoma.